Efficacy and pharmacokinetics of subcutaneous exendin (9-39) in patients with post-bariatric hypoglycemia

Diabetes - GeneralType 2 DiabetesGlycemic Control

Impact of patient and treatment characteristics on glycemic control and hypoglycemia in patients with type 2 diabetes initiated to insulin glargine or NPH: A post hoc, pooled, patient-level analysis of 6 randomized controlled trials

Medicine (Baltimore).

Porcellati F, Lin J, Lucidi P, Bolli GB, Fanelli CG

doi: 10.1097/

Diabetes - GeneralObesity and Bariatric Surgery

Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension)

Circulation.

Schiavon CA, Bersch-Ferreira AC, Santucci EV, Oliveira JD, Torreglosa CR, Bueno PT, Frayha JC, Santos RN, Damian LP, Noujaim PM, Halpern H, Monteiro FLJ, Cohen RV, Uchoa CH, de Souza MG, Amodeo C, Bortolotto L, Ikeoka D, Drager LF, Cavalcanti AB, Berwanger O

doi: 10.1161/

Type 2 Diabetes

Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial

Lancet Diabetes Endocrinol.

Yamada Y, Katagiri H, Hamamoto Y, Deenadayalan S, Navarria A, Nishijima K, Seino Y, PIONEER 9 investigators.

doi: 10.1016/S2213-8587(20)30075-9.

Type 2 Diabetes

Impact of baseline characteristics and beta-cell function on the efficacy and safety of subcutaneous once-weekly semaglutide: a patient-level, pooled analysis of the SUSTAIN 1-5 trials

Diabetes Obes Metab.

Aroda VR, Capehorn MS, Chaykin L, Frias JP, Lausvig NL, Macura S, Lüdemann J, Madsbad S, Rosenstock J, Tabak O, Tadayon S, Bain SC

doi: 10.1111/dom.13896.

Glycemic Control

Efficacy and safety of dulaglutide 3.0 mg and 4.5 mg in patients age < 65 and ≥ 65 years: post hoc analysis of the AWARD-11 trial

Diabetes Obes Metab

Frias JP, Bonora E, Nevárez Ruiz L, Hsia SH, Jung H, Raha S, Cox DA, Bethel MA, Konig M

doi: 10.1111/dom.14469

Diabetes - GeneralType 2 DiabetesGlycemic Control

Efficacy and Safety of Dulaglutide in Older Patients: A Post-hoc Analysis of the REWIND trial

J Clin Endocrinol Metab

Riddle MC, Gerstein HC, Xavier D, Cushman WC, Leiter LA, Raubenheimer PJ, Atisso CM, Raha S, Varnado OJ, Konig M, Lakshmanan M, Franek E

doi: 10.1210/clinem/dgab065

Obesity and Bariatric Surgery

Mental Illness Has a Negative Impact on Weight Loss in Bariatric Patients: a 4-Year Follow-up

J Gastrointest Surg.

Müller M, Nett PC, Borbély YM, Buri C, Stirnimann G, Laederach K, Kröll D

doi: 10.1007/s11605-018-3903-x.

RECOMMENDED

Diabetes - GeneralType 2 DiabetesDiabetic ComplicationsGlycemic ControlObesity and Bariatric Surgery

Microvascular Outcomes in Patients With Diabetes After Bariatric Surgery Versus Usual Care: A Matched Cohort Study

Ann Intern Med.

O'Brien R, Johnson E, Haneuse S, Coleman KJ, O'Connor PJ, Fisher DP, Sidney S, Bogart A, Theis MK, Anau J, Schroeder EB, Arterburn D

doi: 10.7326/M17-2383.

COMMENTED

Further Publications

Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing's Disease: Results From an Open-Label, Multicenter, Single-Arm, Multinational, Expanded-Access Study

Front Endocrinol (Lausanne).

Fleseriu M, Iweha C, Salgado L, Mazzuco TL, Campigotto F, Maamari R, Limumpornpetch P

doi: 10.3389/fendo.2019.00436.

Related content